Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells

12 Jan 2021

Abstract excerpt

The identification of tumor-initiating cells (TICs) has traditionally relied on surface markers including CD133, CD44, CD117, and the aldehyde dehydrogenase (ALDH) enzyme, which have diverse expression across samples. A more reliable indication of TICs may include the expression of embryonic transcription factors that support long-term self-renewal, multipotency, and quiescence. We hypothesize that SOX2, OCT4,...

Topics

Join the communities discussing this publication.

Cancer Cells and Metastasis
Epigenetics and DNA Methylation
Renal and related cancers

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33445692
DOI: 10.3390/cancers13020262

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating CellsPMID 33445692Read ↗

<scp>SOX</scp>2 is required to maintain cancer stem cells in ovarian cancerSemantic proximity Read ↗

An Integrative Transcriptomic Analysis of a Stemness-Associated Gene Set on Ovarian Cancer RecurrenceSemantic proximity Read ↗

SOX2 in cancer stemness: tumor malignancy and therapeutic potentialsSemantic proximity Read ↗

Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis.Semantic proximity Read ↗

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.Semantic proximity Read ↗

A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunitiesSemantic proximity Read ↗

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.Semantic proximity Read ↗

SOX2-high cancer cells exhibit an aggressive phenotype, with increases in stemness, proliferation and invasion, as well as higher metabolic activity and ATP production.Semantic proximity Read ↗

Characterization of primary ovarian cancer cells in different culture systems.Semantic proximity Read ↗

Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumorsSemantic proximity Read ↗

Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2Semantic proximity Read ↗

Isolation and characterization of stem-like cells from a human ovarian cancer cell line.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.